journal article·2020-07-08Open access

Controlled Release of 5-FU from Chi–DHA Nanoparticles Synthetized with Ionic Gelation Technique: Evaluation of Release Profile Kinetics and Cytotoxicity Effect

Mariarosa Ruffo, Ortensia Ilaria Parisi, Francesco Patitucci, Marco Dattilo, Rocco Malivindi, Fabio Amone, Catia Morelli, Alessandra Nigro, Diego Sisci, Francesco Puoci

Abstract

The ionic gelation technique allows us to obtain nanoparticles able to function as carriers for hydrophobic anticancer drugs, such as 5-fluoruracil (5-FU). In this study, reticulated chitosan– docosahexaenoic acid (Chi–DHAr) nanoparticles were synthesized by using a chemical reaction between amine groups of chitosan (Chi) and carboxylic acids of docosahexaenoic acid (DHA) and the presence of a link between Chi and DHA was confirmed by FT-IR, while the size and morphology of the obtained Chi-DHAr nanoparticles was evaluated with dynamic light scattering (DLS) and scanning electron microscopy (SEM), respectively. Drug-loading content (DLC) and drug-loading efficiency (DLE) of 5-FU in Chi-DHAr nanoparticles were 33.74 ± 0.19% and 7.9 ± 0.26%, respectively, while in the non-functionalized nanoparticles (Chir + 5FU), DLC, and DLE were in the ranges of 23.73 ± 0.14%, 5.62%, and 0.23%, respectively. The in vitro release profile, performed in phosphate buffer saline (PBS, pH 7.4) at 37 °C, indicated that the synthetized Chi–DHAr nanoparticles provided a sustained release of 5-FU. Based on the obtained regression coefficient value (R2), the first order kinetic model provided the best fit for both Chir and Chi-DHAr nanoparticles. Finally, cytotoxicity studies of chitosan, 5-FU, Chir, Chir + 5-FU, Chi-DHAr, and Chi-DHAr + 5-FU nanoparticles were conducted. Overall, Chi-DHAr nanoparticles proved to be much more biocompatible than Chir nanoparticles while retaining the ability to release the drug with high efficiency, especially towards specific types of cancerous cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Nanocomposite Films for Food Packaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy

Macrofarm s.r.l., c/o Department of Pharmacy, Health and Nutrition Sciences, University of Calabria, 87036 Rende, Italy

References (23)

Show source-provided references
1. Current Views on Fungal Chitin/Chitosan, Human Chitinases, Food Preservation, Glucans, Pectins and Inulin: A Tribute to Henri Braconnot, Precursor of the Carbohydrate Polymers Science, on the Chitin Bicentennial10.1016/j.carbpol.2011.09.063 ↗
2. A Review of Chitin and Chitosan Applications10.1016/S1381-5148(00)00038-9 ↗
3. Preparation, Characterization, and Antibacterial Activity of Oleic Acid-Grafted Chitosan Oligosaccharide Nanoparticles10.1007/s11515-009-0027-4 ↗
4. Biomedical Applications and Colloidal Properties of Amphiphilically Modified Chitosan Hybrids10.1016/j.progpolymsci.2013.06.009 ↗
5. Méndez, P.A., Vásquez, G.M., Gartner, C., and López, B.L. (2017). Chitosan/OA Nanoparticle as Delivery System for Celecoxib: Parameters Affecting the Particle Size, Encapsulation, and Release. J. Appl. Polym. Sci., 134.10.1002/app.44472 ↗
6. Self-Assembled Nanoparticles Based on Linoleic-Acid Modified Carboxymethyl-Chitosan as Carrier of Adriamycin (ADR)10.1016/j.cap.2006.11.031 ↗
7. The Influence of Multivalent Phosphate Structure on the Properties of Ionically Cross-Linked Chitosan Films for Controlled Drug Release10.1016/S0939-6411(02)00052-8 ↗
8. Oxidation in EPA- and DHA-Rich Oils: An Overview10.1002/lite.201600013 ↗
9. Molecularly Imprinted Polymers for 5-Fluorouracil Release in Biological Fluids10.3390/12040805 ↗
10. Sesbania Gum Based Hydrogel as Platform for Sustained Drug Delivery: An ‘in Vitro’ Study of 5-Fu Release10.1016/j.ijbiomac.2018.02.143 ↗
11. Synthesis and Characterization of Folate Conjugated Chitosan and Cellular Uptake of Its Nanoparticles in HT-29 Cells10.1016/j.carres.2011.01.027 ↗
12. Antimicrobial Properties of Chitosan Nanoparticles: Mode of Action and Factors Affecting Activity10.1007/s12221-017-6690-1 ↗
13. Preparation of Chitosan Nanoparticles and Its Effect on Detached Rice Leaves Infected with Pyricularia Grisea10.1016/j.ijbiomac.2015.11.083 ↗
14. Chitosan Nanoparticles for the Delivery of a New Compound Active against Multidrug-Resistant Staphylococcus Aureus10.1016/j.jddst.2019.101363 ↗
15. Mucoadhesive Olaminosomes: A Novel Prolonged Release Nanocarrier of Agomelatine for the Treatment of Ocular Hypertension10.1016/j.ijpharm.2019.01.070 ↗
16. (2020, March 02). Release Kinetics Study of Poorly Water-Soluble Drugs from Nanoparticles: Are We Doing It Right? | Molecular Pharmaceutics. Available online: https://pubs.acs.org/doi/abs/10.1021/mp500817h.
17. Preparation of Carboxymethyl Chitosan Microspheres and Their Application in Hemostasis10.1017/dmp.2015.133 ↗
18. Parisi, O.I., Ruffo, M., Malivindi, R., Vattimo, A.F., Pezzi, V., and Puoci, F. (2020). Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy. Pharmaceutics, 12.10.3390/pharmaceutics12010041 ↗
19. (2019, December 30). Nanoencapsulation of Zerumbone in Oleic Acid-Modified Chitosan Nanoparticles. In Proceedings of the 2017 International Conference on Computational Biology and Bioinformatics, Newark, NJ, USA, 18–20 October 2017. Available online: https://dl.acm.org/doi/abs/10.1145/3155077.3155097.
20. Cyclodextrin Grafted Calcium Carbonate Vaterite Particles: Efficient System for Tailored Release of Hydrophobic Anticancer or Hormone Drugs10.1039/C6RA12951J ↗
21. Parisi, O.I., Scrivano, L., Candamano, S., Ruffo, M., Vattimo, A.F., Spanedda, M.V., and Puoci, F. (2018). Molecularly Imprinted Microrods via Mesophase Polymerization. Molecules, 23.10.3390/molecules23010063 ↗
22. (2019, December 05). Anticancer Activity of a Quercetin-based Polymer Towards HeLa Cancer Cells. Available online: http://ar.iiarjournals.org/content/32/7/2843.short.
23. Galactosylated Nanostructured Lipid Carriers for Delivery of 5-FU to Hepatocellular Carcinoma10.3109/08982104.2012.662653 ↗